Marshall Wace LLP Makes New $198,000 Investment in Aquestive Therapeutics, Inc. (NASDAQ:AQST)
Marshall Wace LLP purchased a new stake in Aquestive Therapeutics, Inc. (NASDAQ:AQST – Free Report) in the fourth quarter, according to its most recent filing with the SEC. The fund purchased 55,695 shares of the company’s stock, valued at approximately $198,000. Other institutional investors and hedge funds have also made changes to their positions in […]
